US EditionGenetic medicine can leave people with rare mutations behind. But there's new hope
- Patients with rare genetic mutations of cystic fibrosis have fewer treatment options than those with common mutations, as noted by researchers discussing mutation-agnostic gene therapies.
- Kramer-Golinkoff is diagnosed with cystic fibrosis due to a rare mutation, which current treatments cannot address, affecting 40,000 Americans diagnosed with the disease overall.
- Gene therapy trials at Columbia University aim to improve lung function and overall health, providing hope for patients with cystic fibrosis.
- Despite worsening health, Kramer-Golinkoff expresses optimism about future therapies, noting that having trials underway provides hope for those with cystic fibrosis.
Insights by Ground AI
Does this summary seem wrong?
30 Articles
30 Articles
All
Left
11
Center
10
Right
2
Associated Press News+28 Reposted by 28 other sources
Genetic medicine can leave people with rare mutations behind. But there's new hope
People with diseases caused by rare mutations have fewer options and poorer prospects than other patients despite rapid recent advancements in the growing field of genetic science.
·United States
Read Full ArticleCoverage Details
Total News Sources30
Leaning Left11Leaning Right2Center10Last UpdatedBias Distribution48% Left
Bias Distribution
- 48% of the sources lean Left
48% Left
L 48%
C 43%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
